Skip to main content
Suven Pharmaceuticals Limited (NSE:SUVENPHAR)
India flag India · Delayed Price · Currency is INR
1,131.00
-17.70 (-1.54%)
Apr 29, 2025, 3:30 PM IST

Suven Pharmaceuticals Revenue

Suven Pharmaceuticals had revenue of 3.07B INR in the quarter ending December 31, 2024, with 39.73% growth. This brings the company's revenue in the last twelve months to 10.48B, down -10.21% year-over-year. In the fiscal year ending March 31, 2024, Suven Pharmaceuticals had annual revenue of 10.51B, down -21.56%.

Revenue (ttm)
10.48B
Revenue Growth
-10.21%
P/S Ratio
27.89
Revenue / Employee
8.79M
Employees
1,193
Market Cap
292.42B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202410.51B-2.89B-21.56%
Mar 31, 202313.40B201.07M1.52%
Mar 31, 202213.20B3.11B30.75%
Mar 31, 202110.10B1.76B21.10%
Mar 31, 20208.34B-730.13M-8.05%
Mar 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 516.03B
Divi's Laboratories 90.78B
Cipla 267.20B
Mankind Pharma 116.41B
Apollo Hospitals Enterprise 211.46B
Zydus Lifesciences 222.47B
Aurobindo Pharma 309.22B
Alkem Laboratories 127.57B
Revenue Rankings

Suven Pharmaceuticals News

More News